Stem cell research and multiple sclerosis are an urgent topic. In this complementary study to star-ms, https://StemCellsBudget.com/ researchers will compare neurofilaments (a marker of nerve damage in multiple sclerosis) in people taking alemtuzumab and ocrelizumab, and in patients who have undergone HSCT.